Virus | Particle:PFU | Ro | Ro/Particle:PFU | Transmission | Notes |
---|---|---|---|---|---|
Ebola (-ssRNA) | 511 [12] | 1.5–1.9 [21] | 2.9 × 10–3–3.7 × 10–3 | Bodily Fluids | Particle:PFU from strain at Walter Reed Medical Center [1]; Ro from 2014 epidemic [21] |
Influenza A* (-ssRNA) | 20–509 | 0.9–2.1 [6] | 4.2 × 10–2–4.5 × 10–2 | Predominantly Respiratory Droplet | Seasonal strains |
Smallpox (dsDNA) | 6.87 [23] | 1.46 × 10–1–14.6 | Small particle aerosol | Ro from 1967 outbreak smallpox | |
VZV (dsDNA) | 40000 [14] | 10–12 [24] | 2.5 × 10–4–3 × 10–4 | Small particle aerosol; Vertical | Ro pre-vaccine |
Adenoviradae (dsDNA) | 20–100 [9] | 2.34 [24] | 2.3 × 10–2–1.2 × 10–1 | Fecal–oral; Respiratory | |
Rotavirus (dsRNA) | 10 [9] | 78.8 [26] | 7.88 | Fecal–oral; Droplet | Ro pre-vaccine estimation |
HSV-1* (dsDNA) | 50–200 [9] | 2–5 [28] | 2 × 10–2–4 × 10–2 | Bodily Fluids, Sexual, Vertical | P:PFU antecedently recorded as 10:1 |
HSV-2 (dsDNA) | 50–200 [9] | 2.07 [29] | 1 × 10–2–4 × 10–2 | Sexual; Vertical | |
Polio* (+ ssRNA) | 5–6 [24] | 6 × 10–3–1.4 × 10–1 | Fecal–oral | ||
HPV (dsDNA) | 10000 [9] | 0.52–1.2 [30] | 5.2 × 10–5–1.2 × 10–4 | Sexual | STI strains; Ro assumes untreated population; ignores autoinnoculation |
Coxsackie A (+ ssRNA) | 210 [31] | 2.5 [32] | 1.2 × 10–3 | Fecal–oral | |
Measles* (-ssRNA) | 12–18 [3] | 9 × 10–2–1.2 | Small particle aerosol | Ro pre-vaccine | |
RSV (-ssRNA) | 3200 [33] | 3.8 × 10–4–9.4 × 10–4 | Respiratory droplet; Fomite | ||
Mumps* (-ssRNA) | 100–1000 [13] | 10–12 [24] | 1.2 × 10–2–1 × 10–1 | Respiratory droplet | Ro pre-vaccine |
SARS-CoV (+ ssRNA) | 360 [36] | 2.2–3.6 [4] | 6.1 × 10–4–1 × 10–2 | Respiratory droplet | Particle:PFU from gRNA |
Rhinovirus* (+ ssRNA) | 2–3 [35] | 3 × 10–3–6.7 × 10–2 | Respiratory droplet | Inferred P:PFU; Ro seasonal change | |
SARS-CoV-2 (+ ssRNA) | 2.6–5.7 [27] | 5.7 × 10–6–2.6 × 10–3 | Respiratory droplet; possible aerosol | Early studies suggest Ro closer to 2.6 |